Lebanon
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Lebanon (LB)
2000 | 123.9 thousand |
2011 | 527.9 thousand |
2024 | 439.7 thousand |
2050 | 484.2 thousand |
Lebanon is one of the 21 countries and territories in the IDF Middle-East and North Africa Region.
Data source(s) used for the diabetes estimates in adults:
- Bou-Orm I, Adib S East Mediterr Health J. 2020 Feb 1;26(2):182-8. PMID: 32141596
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 123.9 | 527.9 | 439.7 | 484.2 |
Age-standardised prevalence of diabetes, % | - | 19.6 | 12.3 | 14.5 |
Proportion of people with undiagnosed diabetes, % | - | - | 26.1 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 114.9 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 234.6 | 241.4 |
Age-standardised prevalence of IFG, % | - | - | 7.1 | 7.3 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 206.2 | 251.7 | 247.1 |
Age-standardised prevalence of IGT, % | - | 7.5 | 7.5 | 7.6 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 4,525.0 | 2,861.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 14.5 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 768.1 | 784.7 |
Total diabetes-related health expenditure, ID million | - | - | 1,215.0 | 1,241.3 |
Diabetes-related health expenditure per person, USD | - | 767.0 | 1,746.8 | 1,620.5 |
Diabetes-related health expenditure per person, ID | - | - | 2,763.1 | 2,563.3 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 12,438.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 3,174.3 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 1,875.0 | 2,788.6 | 3,229.5 | 3,333.4 |
Population of children and adolescents (0-19 y) | - | - | 2,043,619.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 123.9 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 1,875.0 |
Population of children and adolescents (0-19 y) | - |